MHY 908
|
- $53 - $3041
- Product name: MHY 908
- CAS: 1393371-39-5
- MF: C17H14ClNO3S
- MW: 347.82
- EINECS:
- MDL Number:
- Synonyms:MHY 908;MHY908,MHY-908;Propanoic acid, 2-[4-(5-chloro-2-benzothiazolyl)phenoxy]-2-methyl-
16 prices
Selected condition：
Brand
- aablocks
- AK Scientific
- Axon Medchem
- Biosynth
- Cayman Chemical
- ChemScene
- TRC
Package
- 500μg
- 1mg
- 5mg
- 10mg
- 25mg
- 50mg
- 500??g
- Manufactureraablocks
- Product numberAA00A1DE
- Product descriptionMHY908 ≥98%
- Packaging1mg
- Price$90
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00A1DE
- Product descriptionMHY908 99%
- Packaging5mg
- Price$171
- Updated2026-05-28
- Buy
- Manufactureraablocks
- Product numberAA00A1DE
- Product descriptionMHY908 99%
- Packaging25mg
- Price$446
- Updated2026-05-28
- Buy
- ManufacturerAK Scientific
- Product number6613DT
- Product description2-(4-(5-Chlorobenzo[d]thiazol-2-yl)phenoxy)-2-methylpropanoicacid
- Packaging5mg
- Price$433
- Updated2021-12-16
- Buy
- ManufacturerAxon Medchem
- Product numberAxon2402
- Product descriptionMHY 908
- Packaging25mg
- Price$324.5
- Updated2026-05-19
- Buy
- ManufacturerAxon Medchem
- Product numberAxon2402
- Product descriptionMHY 908
- Packaging5mg
- Price$104.5
- Updated2026-05-19
- Buy
- ManufacturerBiosynth
- Product numberTFC37139
- Product descriptionMHY908
- Packaging10mg
- Price$1165.6
- Updated2026-06-05
- Buy
- ManufacturerBiosynth
- Product numberTFC37139
- Product descriptionMHY908
- Packaging25mg
- Price$1900.5
- Updated2026-06-05
- Buy
- ManufacturerBiosynth
- Product numberTFC37139
- Product descriptionMHY908
- Packaging50mg
- Price$3041
- Updated2026-06-05
- Buy
- ManufacturerCayman Chemical
- Product number18293
- Product descriptionMHY908 ≥98%
- Packaging10mg
- Price$559
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number18293
- Product descriptionMHY908 ≥98%
- Packaging500μg
- Price$53
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number18293
- Product descriptionMHY908 ≥98%
- Packaging1mg
- Price$90
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number18293
- Product descriptionMHY908 ≥98%
- Packaging5mg
- Price$332
- Updated2026-04-30
- Buy
- ManufacturerChemScene
- Product numberCS-0067724
- Product descriptionMHY908
- Packaging500??g
- Price$122
- Updated2026-06-04
- Buy
- ManufacturerTRC
- Product numberM340985
- Product descriptionMHY908
- Packaging10mg
- Price$450
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberM340985
- Product descriptionMHY908
- Packaging25mg
- Price$905
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| aablocks | AA00A1DE | MHY908 ≥98% | 1mg | $90 | 2026-05-28 | Buy |
| aablocks | AA00A1DE | MHY908 99% | 5mg | $171 | 2026-05-28 | Buy |
| aablocks | AA00A1DE | MHY908 99% | 25mg | $446 | 2026-05-28 | Buy |
| AK Scientific | 6613DT | 2-(4-(5-Chlorobenzo[d]thiazol-2-yl)phenoxy)-2-methylpropanoicacid | 5mg | $433 | 2021-12-16 | Buy |
| Axon Medchem | Axon2402 | MHY 908 | 25mg | $324.5 | 2026-05-19 | Buy |
| Axon Medchem | Axon2402 | MHY 908 | 5mg | $104.5 | 2026-05-19 | Buy |
| Biosynth | TFC37139 | MHY908 | 10mg | $1165.6 | 2026-06-05 | Buy |
| Biosynth | TFC37139 | MHY908 | 25mg | $1900.5 | 2026-06-05 | Buy |
| Biosynth | TFC37139 | MHY908 | 50mg | $3041 | 2026-06-05 | Buy |
| Cayman Chemical | 18293 | MHY908 ≥98% | 10mg | $559 | 2026-04-30 | Buy |
| Cayman Chemical | 18293 | MHY908 ≥98% | 500μg | $53 | 2026-04-30 | Buy |
| Cayman Chemical | 18293 | MHY908 ≥98% | 1mg | $90 | 2026-04-30 | Buy |
| Cayman Chemical | 18293 | MHY908 ≥98% | 5mg | $332 | 2026-04-30 | Buy |
| ChemScene | CS-0067724 | MHY908 | 500??g | $122 | 2026-06-04 | Buy |
| TRC | M340985 | MHY908 | 10mg | $450 | 2021-12-16 | Buy |
| TRC | M340985 | MHY908 | 25mg | $905 | 2021-12-16 | Buy |
Properties
Boiling point :523.6±58.0 °C(Predicted)
Density :1.381±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 25 mg/ml; DMF:PBS (pH 7.2) (1:8): 0.1 mg/ml; DMSO: 10 mg/ml; Ethanol: 1 mg/ml
form :A crystalline solid
pka :3.15±0.10(Predicted)
Density :1.381±0.06 g/cm3(Predicted)
storage temp. :Store at -20°C
solubility :DMF: 25 mg/ml; DMF:PBS (pH 7.2) (1:8): 0.1 mg/ml; DMSO: 10 mg/ml; Ethanol: 1 mg/ml
form :A crystalline solid
pka :3.15±0.10(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Peroxisome proliferator-activated receptors (PPARs) are activated by fatty acids and eicosanoids as well as antidyslipidemic agents. Among the receptor isotypes, PPARα demonstrates a particular role in fatty acid oxidation, whereas PPARγ is known to be involved in adipocyte differentiation and lipid storage. MHY908 is a dual agonist of PPARα and PPARγ. MHY908 has been shown to enhance the binding and transcriptional activity of PPARα and PPARγ in AC2F cells (5 μM) more potently than fenofibrate or rosiglitazone and to reduce serum glucose, triglyceride, and insulin levels in db/db mice (3 mg/kg). It is also reported to improve hepatic steatosis by enhancing CPT-1 levels and to reduce endoplasmic reticulum stress and JNK activation in the livers of db/db mice, leading to reduced insulin resistance.Related product price
-
Gliquidone
$20-1066.5 -
NUCIFERINE
$10-1650 -
Isoliquiritigenin
$5-2656.5
